news

「ロート子どもの夢基金」第4回助成事業の募集開始

グロビン蛋白分解物の摂取により、脂質代謝に加えて、筋肉の量と持久的運動能力に良好な変化を確認

"Cell-tech cosmetics" ranked among the top 30 in Nikkei Trendy's 2027 hit product predictions and won the industry-specific grand prize (beauty).

A new mechanism by which chondroitin protects the surface of the eye has been discovered.

Received the JSEV Encouragement Award at the 13th Annual Meeting of the Japanese Society for Extracellular Vesicles. Presented research results on phytoexosomes derived from algae in Okinawa.

New Release: “Obagi C Serum Cleansing Oil,” Japan’s First Product Featuring “VC First Technology,” Developed Based on Vitamin C Research from “Obagi ®”

Becoming a strategic corporate partner of the Hong Kong government. Accelerating our growth strategy in Asia, starting from Hong Kong.

How does the desire to "want to use it again" arise? Exploring the process of becoming addicted to lip balm through continued use.

Tackling the cleansing challenge with pure vitamin C. Verifying the effects of vitamin C and developing new cleansing formulation technology.

Rohto Pharmaceutical Co., Ltd. holds "Phytoexosome Research Meeting"

ROHTO V5 Vision Power New Release

Rohto Pharmaceutical, Rohto Wellcoat, and Nissui have collaborated for the first time. The "Brilloth Donburi" is born, a dish that encourages health through "eating fish."

Presented at the 36th IFSCC World Congress: Discovery of a new moisturizing function in phytoexosomes utilizing sake fermentation technology.

Presented at the 36th IFSCC World Congress. Research toward the construction of a stimulus perception evaluation system using a three-dimensional cultured skin model incorporating iPS cell-derived sensory nerve cells.

Presented at the 36th IFSCC World Congress. Focusing on the structure of the cream film after application to the skin, we have elucidated a part of the mechanism by which moisture is retained.

Selected as one of the Top 10 oral presentations at the 36th IFSCC World Congress. The presentation suggested a new possibility: "Maintaining soft skin" can guide aging cells back to a youthful state.

Rohto Pharmaceutical and Taiyo Life's Institute for Research on Aging Society Conduct their first joint survey. Approximately 60-70% of parents are conscious of their children's eye health.

Regarding the conclusion of an exclusive domestic distribution agreement with PharmaBio Co., Ltd. for "PAL-222," a Regenerative medicine product currently under development for myopic chorioretinal atrophy.

Cordyceps sinensis, a traditional medicinal ingredient, is suggested to activate neural circuit formation and energy metabolism in the brain.

"THE THE LYPO," a beauty supplement containing two types of vitamin C—sustained-release and fast-acting—has been renewed.

Apology and Notice Regarding the Leakage of Customer Personal Data Due to Unauthorized Access

Regarding the status of the investigation into unauthorized access to our systems

Regarding the possibility of unauthorized access to our system

Announcement of the publication of "Rohto Health White Paper 2026"

Notice Regarding Voluntary Recall of Vietnamese-Made Eye Drops in the United States

Regarding support for the 2026 Kumamoto Earthquake

Rohto launches "Rohto Medical Eye," a website for healthcare professionals.

Regarding the issue of the old DRX brand website URL being redirected to a fraudulent site.

Initiatives to Ensure Safety in Cell Therapy

Notice of changes to packaging specifications due to environmental considerations

Publication of "Rohto Health White Paper 2025"

Please purchase from authorized Obagi retailers.

Initiatives to Ensure Safety in Cell Therapy

Setting new health and productivity management indicators for 2030

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Revision of the "Multi-Stakeholder Policy"

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Rohto Group formulates "Basic Policy on Customer Harassment"

Please be careful of suspicious investment solicitations related to our company.

Beware of counterfeit "Lush Rich" products

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

「加齢皮膚」に特化した研究基金『加齢皮膚医学研究基金：ロート賞』第20回受賞者を発表いたします

The recipients of the 17th Rohto Women's Health Science Research Award have been decided.

The winners of the 31st ROHTO AWARD research grants have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

「加齢皮膚」に特化した研究基金『加齢皮膚医学研究基金：ロート賞』第19回受賞者を発表いたします

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

The 16th recipients of the Rohto Women's Health Science Research Award have been announced

研究助成『ROHTO AWARD（ロート アワード）』第30回 受賞者が決定いたしました。

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

「加齢皮膚」に特化した研究基金『加齢皮膚医学研究基金：ロート賞』第18回受賞者を発表いたします

The 4th Rohto Regenerative medicine Forum was held

The 15th recipients of the Rohto Women's Health Science Research Award have been announced

研究助成『ROHTO AWARD（ロート アワード）』第29回 受賞者が決定いたしました。

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

「加齢皮膚」に特化した研究基金『加齢皮膚医学研究基金：ロート賞』第17回受賞者を発表いたします

The 3rd Rohto Regenerative medicine Forum was held

The 14th recipients of the Rohto Women's Health Science Research Award have been announced